ICH E Guidelines: What QA and QP Need to Know
Discover the principles of the ICH E Guidelines for Clinical Trials and GCP: responsibilities, risks, documentation, and data quality, explained for QA/QP.
Read the article →GXP ACADEMY · ICH GUIDELINES
Practical analysis of the ICH Q, E, M and S families: pharmaceutical development, quality and risk, impurities, stability, CTD/eCTD dossiers, clinical trials and lifecycle management. Built to clarify what each guideline requires, how it connects to others and what evidence is needed in practice.
ICH Q · E · M · S
Quality, risk, impurities, regulatory dossiers and clinical trials explained through connections, operational criteria and expected evidence.
Discover the principles of the ICH E Guidelines for Clinical Trials and GCP: responsibilities, risks, documentation, and data quality, explained for QA/QP.
Read the article →
GMP and ICH Q8–Q12 Audits: What Inspectors Check and How to Be Audit-Ready.
Read the article →
Complete guide to the ICH M Guidelines: CTD, eCTD, stability, bioequivalence and global submissions. Ideal for RA, QA and CMC.
Read the article →
Elemental and mutagenic impurities: what EMA/FDA inspectors look for — and how to keep your dossier audit-ready.
Read the article →
Implementing Q8, Q9, Q10, and Q12: Operating method, checklist, and pitfalls to avoid.
Read the article →
Prepare for EMA/FDA inspections: correctly apply the ICH E Guidelines on sponsor oversight, TMF, data integrity and risk management. Guide for QA/QP.
Read the article →